Published in Biometrics on March 01, 1993
On Identifying Minimum Efficacious Doses in Combination Drug Trials. Stat Biopharm Res (2009) 0.81
Assessing interactions for fixed-dose drug combinations in tumor xenograft studies. J Biopharm Stat (2012) 0.79
Expected loss functions as additional measures to assess performance of multiple testing procedures for combination drug dose finding. Pharm Stat (2012) 0.75
Assessing interactions for fixed-dose drug combinations in subcutaneous tumor xenograft studies. Pharm Stat (2013) 0.75
Myonecrosis after revascularization procedures. J Am Coll Cardiol (1998) 2.11
Cable parameters, sodium, potassium, chloride, and water content, and potassium efflux in isolated external intercostal muscle of normal volunteers and patients with myotonia congenita. J Clin Invest (1971) 1.87
Sodium, potassium, and chloride fluxes in intercostal muscle from normal goats and goats with hereditary myotonia. J Gen Physiol (1966) 1.72
The risks associated with short-term placebo-controlled antihypertensive clinical trials: a descriptive meta-analysis. J Hum Hypertens (2008) 1.51
Combination products as first-line pharmacotherapy. Arch Intern Med (1994) 1.41
Variability of myotonic signs in myotonic goats. Am J Vet Res (1968) 1.15
Effects of yohimbine on squid axons. Biophys J (1978) 0.97
Effect of methyldopa on plasma renin activity in man. Circ Res (1969) 0.93
On sample size and inference for two-stage adaptive designs. Biometrics (2001) 0.92
Diphenylhydantoin inhibition of sodium conductance in squid giant axon. Proc Natl Acad Sci U S A (1972) 0.90
Does phospholipid flip-flop affect axon potassium channels? Biophys J (1975) 0.90
Sodium currents in human skeletal muscle fibers. Muscle Nerve (1982) 0.89
Determination of K(+)-channel relaxation times in squid axon membrane by Hodgkin-Huxley and by direct linear analysis. Biophys Chem (1991) 0.86
Temperature effects on cable parameters and K efflux in normal and myotonic goat muscle. Am J Physiol (1972) 0.84
Two-stage tests for studying monotherapy and combination therapy in two-by-two factorial trials. Stat Med (1993) 0.83
Short and long-acting oral nitrates for stable angina pectoris. Cardiovasc Drugs Ther (1994) 0.81
Exposing patients with chronic, stable, exertional angina to placebo periods in drug trials. JAMA (1991) 0.79
Ion content, potassium efflux and cable properties of myotonic, human, external-intercostal muscle. Trans Am Neurol Assoc (1971) 0.77
Assessment of antihypertensive activity in the regulatory setting. Blood Press Monit (2001) 0.77
Ointments and transdermal nitroglycerin patches for stable angina pectoris. Cardiovasc Drugs Ther (1994) 0.76
Efficacy evaluation for monotherapies in two-by-two factorial trials. Biometrics (1995) 0.76
Antihypertensive effects of lofexidine in patients with essential hypertension. Br J Clin Pharmacol (1982) 0.75
Combination products as first-line pharmacotherapy. Arch Intern Med (1995) 0.75
Metabolism of benzocaine during percutaneous absorption in the hairless guinea pig: acetylbenzocaine formation and activity. Skin Pharmacol (1996) 0.75
Ineffectiveness of lysergic acid diethyl amide-25 (LSD) on altering Na-K currents in squid giant axon. Experientia (1974) 0.75
Potassium permeability in isolated skeletal muscle from mice with muscular dystrophy. Am J Physiol (1974) 0.75
On the trough-to-peak ratio of drug effect in antihypertensive trials. Am J Hypertens (1996) 0.75
Charcoal hemoperfusion: a method for removing PCP from the blood and body in overdose cases. J Psychedelic Drugs (1981) 0.75
Ouabain conversion of aconitine-induced atrial tachycardias. Life Sci I (1971) 0.75
A computer program for the generalized chi-square analysis of competing risks grouped survival data (CRISCAT). Comput Programs Biomed (1978) 0.75
Evaluation of bretylium tosylate for the treatment of premature ventricular contractions. Circulation (1972) 0.75
Designing a clinical trial to demonstrate prevention of ulcer recurrence: modelling simulation approaches. Stat Med (1988) 0.75